Site-Specific Conjugation of Boron-Containing Dendrimers to Anti-EGF Receptor Monoclonal Antibody Cetuximab (IMC-C225) and Its Evaluation as a Potential Delivery Agent for Neutron Capture Therapy-Reference-Cited by-同舟云学术

Site-Specific Conjugation of Boron-Containing Dendrimers to Anti-EGF Receptor Monoclonal Antibody Cetuximab (IMC-C225) and Its Evaluation as a Potential Delivery Agent for Neutron Capture Therapy

Published:2003-12-10 Issue:1 Volume:15 Page:185-194
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Wu Gong¹,Barth Rolf F.¹,Yang Weilian¹,Chatterjee Madhumita¹,Tjarks Werner¹,Ciesielski Michael J.¹,Fenstermaker Robert A.¹

Affiliation:

1. Department of Pathology and College of Pharmacy, The Ohio State University, Columbus, Ohio 43210 and Department of Neurosurgery, Roswell Park Cancer Institute, Buffalo, New York 14263

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc0341674

Reference71 articles.

1. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metallacarboranes in Medicinal Chemistry: Current Advances and Future Perspectives;Journal of Medicinal Chemistry;2024-05-21

2. Targeted strategies to deliver boron agents across the blood–brain barrier for neutron capture therapy of brain tumors;International Journal of Pharmaceutics;2024-01

3. Green Synthesis of Organic Nanomaterials and Their Applications;Biogenic Wastes-Enabled Nanomaterial Synthesis;2024

4. Amine-terminated dendrimers: A novel method for diagnose, control and treatment of cancer;Cancer Epigenetics and Nanomedicine;2024

5. Dendritic Structures Functionalized with Boron Clusters, in Particular Carboranes, and Their Biological Properties;Pharmaceutics;2023-08-10